Advances in Care host Erin Welsh is joined by Dr. Cara Agerstrand, director of the Medical ECMO Program at NewYork-Presbyterian and Columbia, and Dr. Matthew Baldwin, critical care specialist and research lead for Columbia’s Baldwin Lab which focuses on the study of critical illness survivorship. They discuss the strength of NewYork-Presbyterian and Columbia’s critical care teams, including how they have established a world-renowned expertise in managing patients on rescue therapies like extra-corporeal membrane oxygenation (ECMO), the most advanced form of cardiopulmonary life support. Their conversation explores how their program treats the sickest respiratory and cardiac failure patients, why expertise in ECMO remains relatively uncommon nationwide, and how utilization has evolved from early pediatric use to post H1N1 and COVID surges. They also explore how the Baldwin Lab leads the field of critical care medicine for research on understanding the biological factors of why some patients fully recover from ICU stays and others do not, as well as physical, mental, and emotional wellbeing for patients.